The Latest in Leukemia, Myelodysplasia, Transplantation

Highly effective in Ph-negative B-cell ALL: Hyper-CVAD with sequential blinatumomab

December 11, 2020

Leukemia, Myelodysplasia, Transplantation

Patients with lung and blood cancers most vulnerable to COVID-19

December 10, 2020

Extended virus shedding after COVID-19 in some patients with cancer

December 10, 2020

Black race linked to poorer survival in AML

December 10, 2020

Fixed duration ibrutinib/venetoclax appears feasible for some CLL/SLL patients

December 6, 2020

Leukemia, Myelodysplasia, Transplantation

In MDS, transplant ups survival in elderly and may be reimbursed

December 5, 2020

Leukemia, Myelodysplasia, Transplantation

Cancer rates on the rise in adolescents and young adults

December 4, 2020

Immune checkpoint inhibitors don’t increase COVID-19 incidence or mortality, studies suggest

November 25, 2020

‘Impressive’ outcomes sans chemo in poor-prognosis ALL

November 18, 2020

Leukemia, Myelodysplasia, Transplantation

Immunotherapy for ALL: Roles emerge in R/R disease, MRD+ disease

November 17, 2020

Leukemia, Myelodysplasia, Transplantation

Using telehealth to deliver palliative care to cancer patients

November 17, 2020

Prevention of HMA failure a goal for high-risk MDS posttransplant

November 13, 2020

Leukemia, Myelodysplasia, Transplantation

New cancer drugs may have saved more than 1.2 million Americans

November 12, 2020

Ibrutinib associated with decreased circulating malignant cells and restored T-cell function in CLL patients

November 10, 2020

Leukemia, Myelodysplasia, Transplantation

Beat AML: Precision medicine strategy feasible, superior to SOC for AML

November 10, 2020

Leukemia, Myelodysplasia, Transplantation